The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer [Meeting Abstract]
dc.authorid | Eralp, Yesim/0000-0001-9603-4755; | |
dc.authorwosid | Uygun, Kazim/AAG-7880-2022 | |
dc.authorwosid | Saip, pınar/AAT-1500-2020 | |
dc.authorwosid | Aydiner, Adnan/AAU-4591-2020 | |
dc.authorwosid | Tas, Faruk/AAF-8751-2019 | |
dc.authorwosid | Eralp, Yesim/AAD-7194-2020 | |
dc.authorwosid | Uygun, Kazim/AFL-7917-2022 | |
dc.contributor.author | Karagol, Hakan | |
dc.contributor.author | Saip, Pinar | |
dc.contributor.author | Uygun, Kazim | |
dc.contributor.author | Caloglu, Murat | |
dc.contributor.author | Eralp, Yesim | |
dc.contributor.author | Tas, Faruk | |
dc.contributor.author | Aydiner, Adnan | |
dc.date.accessioned | 2024-06-12T11:22:52Z | |
dc.date.available | 2024-06-12T11:22:52Z | |
dc.date.issued | 2006 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description | 31st Congress of the European-Society-for-Medical-Oncology -- SEP 29-OCT 03, 2006 -- Istanbul, TURKEY | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | European Soc Med Oncol | en_US |
dc.identifier.endpage | 174 | en_US |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issn | 1569-8041 | |
dc.identifier.startpage | 174 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/26102 | |
dc.identifier.volume | 17 | en_US |
dc.identifier.wos | WOS:000248078900563 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Annals Of Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer [Meeting Abstract] | en_US |
dc.type | Conference Object | en_US |